Future Perspectives of NMDAR in CNS Disorders
Neurodegenerative diseases such as Alzheimer’s and Parkinson’s diseases are among the leading causes of physical and cognitive disability across the globe. Fifty million people worldwide suffer these diseases, and that number is expected to rise as the population ages. Ictus is another pathology tha...
Saved in:
| Main Authors: | Toni Capó, Joan Biel Rebassa, Iu Raïch, Jaume Lillo, Pau Badia, Gemma Navarro, Irene Reyes-Resina |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-02-01
|
| Series: | Molecules |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1420-3049/30/4/877 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cannabidiol as a multifaceted therapeutic agent: mitigating Alzheimer's disease pathology and enhancing cognitive function
by: Iu Raïch, et al.
Published: (2025-05-01) -
Impaired wound healing in Parkinson’s disease: a hypothesis on altered epidermal growth factor (EGF) and N-methyl-D-aspartate (NMDA) signaling in keratinocytes
by: Caroline Liu, et al.
Published: (2025-05-01) -
Spatiotemporal terahertz modulation enhances NMDAR-mediated miniature EPSCs
by: Shaolei Jiang, et al.
Published: (2025-07-01) -
Application of optical coherence tomography in neurodegenerative diseases: a focus on Parkinson’s, Alzheimer’s, and Schizophrenia in Bulgarian patients
by: Alina Y. Levi, et al.
Published: (2024-12-01) -
Stress enhances expression of calcium‐binding proteins and NMDAR subunit genes in the rat hippocampus
by: Aravind Parthasarathy, et al.
Published: (2024-06-01)